Aleksandr Eismant
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 27, 2025
Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival.Elisabetta Perrone, Maria Lucia Calcagni, Lucia Leccisotti
|Jun 13, 2025
The Influence of Radioligand Therapy on Immunogenicity Against SARS-CoV-2-A Retrospective Single-Arm Cohort Study of Metastatic Prostate Cancer Patients Receiving PSMA Radioligand Therapy.Carsten S Kramer, Aleksandr Eismant, Aditi Mishra
|Feb 13, 2025
Long-Term Safety and Survival Outcomes of [225Ac]Ac-PSMA (Prostate-Specific Membrane Antigen) and [225Ac]Ac-/[177Lu]Lu-PSMA (TANDEM) Radioligand Therapy (PRLT) in Metastatic Castration-Resistant Prostate Cancer.Elisabetta Perrone, Alessandro Giordano, Maria Lucia Calcagni
|May 11, 2024
Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas.Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant
Pageof 1
Frequent Collaborators
3 joint publications
Elisabetta Perrone
3 joint publications
Richard Paul Baum
2 joint publications
Lucia Leccisotti
2 joint publications
Tanay Parkar
1 joint publications
Mikkel Andreassen
1 joint publications
Andreas Kjaer
1 joint publications
Kriti Ghai
1 joint publications
Jörg Müller
1 joint publications
Carsten S Kramer
1 joint publications
Lukas Greifenstein
